STEMLINE THERAPEUTICS INC
DelistedCIK 1264587fmd_0SCHMX2M6X307PMM19H037R1QDManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2004 to Mar 31, 2020, 41 periods
Latest annual · FY2018
Millions- Total revenues
- 1
- Operating income
- (79)
- Net income
- (77)
Latest quarter · Q1 FY2020
Millions- Total revenues
- 9
- Gross profit
- 8
- Operating income
- (22)
- Net income
- (21)
- Free cash flow
- (14)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2015 to FY2018
- n/m
- Net income, 5 yearsFY2014 to FY2019
- n/m
STEMLINE THERAPEUTICS INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2019 | FY2018 | Change | Source |
|---|---|---|---|---|
| Operating income | -$79.2 million | -$86.3 million | 10-K 2020-03-16 · proof | |
| Net income | -$76.8 million | -$85 million | 10-K 2020-03-16 · proof | |
| Cash from operating activities | -$67.7 million | -$72.2 million | 10-K 2020-03-16 · proof | |
| Total assets | $187 million | $63.5 million | +194.5% | 10-K 2020-03-16 · proof |
| Total liabilities | $23.4 million | $21.3 million | +9.7% | 10-K 2020-03-16 · proof |
| Cash and cash equivalents | $13.6 million | $9.4 million | +43.6% | 10-K 2020-03-16 · proof |
- What was STEMLINE THERAPEUTICS INC's operating income in fiscal 2019?
- STEMLINE THERAPEUTICS INC reported operating income of -$79.2 million for fiscal 2019 (the year ended Dec 31, 2019), against -$86.3 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2020. SEC
- What was STEMLINE THERAPEUTICS INC's net income in fiscal 2019?
- STEMLINE THERAPEUTICS INC reported net income of -$76.8 million for fiscal 2019 (the year ended Dec 31, 2019), against -$85 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2020. SEC
- What was STEMLINE THERAPEUTICS INC's cash from operating activities in fiscal 2019?
- STEMLINE THERAPEUTICS INC reported cash from operating activities of -$67.7 million for fiscal 2019 (the year ended Dec 31, 2019), against -$72.2 million the year before. Source: the 10-K filed with the SEC on Mar 16, 2020. SEC
- What are STEMLINE THERAPEUTICS INC's total assets?
- As of Dec 31, 2019, STEMLINE THERAPEUTICS INC reported total assets of $187 million, against $63.5 million a year earlier (+194.5%). Source: the 10-K filed with the SEC on Mar 16, 2020. SEC
- What are STEMLINE THERAPEUTICS INC's total liabilities?
- As of Dec 31, 2019, STEMLINE THERAPEUTICS INC reported total liabilities of $23.4 million, against $21.3 million a year earlier (+9.7%). Source: the 10-K filed with the SEC on Mar 16, 2020. SEC
- What are STEMLINE THERAPEUTICS INC's cash and cash equivalents?
- As of Dec 31, 2019, STEMLINE THERAPEUTICS INC reported cash and cash equivalents of $13.6 million, against $9.4 million a year earlier (+43.6%). Source: the 10-K filed with the SEC on Mar 16, 2020. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1264587&period_type=annual&limit=5"Information only, not investment advice.